Cutting-Edge Basic Research Awards (CEBRA) (R21 Clinical Trial Optional)
Cutting-Edge Basic Research Awards (CEBRA) (R21 Clinical Trial Optional) is a published development and funding opportunity on Contexium. The donor or funder is National Institutes of Health. Project location(s): United States. Applications close on 11 Aug 2027. Budget: 150,000 USD. The National Institute on Drug Abuse (NIDA) Cutting-Edge Basic Research Award (CEBRA) is designed to foster highly innovative or conceptually creative research related to the etiology, pathophysiology, prevention, or treatment of substance use disorders (SUDs). It supports high-risk and potentially…
Opportunity overview
- Project name
- Cutting-Edge Basic Research Awards (CEBRA) (R21 Clinical Trial Optional)
- Donor
- National Institutes of Health
Key details
- Opportunity start date
- Opportunity end date
- Project location(s)
- United States
- Budget
- 150,000
- Currency
- US Dollar
Summary
Frequently asked questions
What is Cutting-Edge Basic Research Awards (CEBRA) (R21 Clinical Trial Optional)?
Cutting-Edge Basic Research Awards (CEBRA) (R21 Clinical Trial Optional) is a published development and funding opportunity on Contexium. The donor or funder is National Institutes of Health. Project location(s): United States. Applications close on 11 Aug 2027. Budget: 150,000 USD. The National Institute on Drug Abuse (NIDA) Cutting-Edge Basic Research Award (CEBRA) is designed to foster highly innovative or conceptually creative research related to the etiology, pathophysiology, prevention, or treatment of substance use disorders (SUDs). It supports high-risk and potentially…
Who is funding Cutting-Edge Basic Research Awards (CEBRA) (R21 Clinical Trial Optional)?
Cutting-Edge Basic Research Awards (CEBRA) (R21 Clinical Trial Optional) is funded by National Institutes of Health.
When is the deadline to apply for Cutting-Edge Basic Research Awards (CEBRA) (R21 Clinical Trial Optional)?
The application deadline is 11 Aug 2027 00:00 (UTC).
Where will the Cutting-Edge Basic Research Awards (CEBRA) (R21 Clinical Trial Optional) project take place?
The project location(s) are: United States.
What is the budget for Cutting-Edge Basic Research Awards (CEBRA) (R21 Clinical Trial Optional)?
The available budget is 150,000 USD.
How can I apply for Cutting-Edge Basic Research Awards (CEBRA) (R21 Clinical Trial Optional)?
Create a free Contexium account to view the full opportunity details and submit an application via the marketplace.